Edward Pershing
Equibles does not estimate personal net worth.
About Edward Pershing
Edward Pershing is recorded as CEO at Provectus Biopharmaceuticals, Inc. (PVCT). The proxy statement of Provectus Biopharmaceuticals, Inc. reports total compensation of $315,000 for Edward Pershing in fiscal 2025, including a base salary of $240,000. Disclosed compensation is on record for 3 fiscal years. Provectus Biopharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Provectus Biopharmaceuticals, Inc. includes Dominic Rodrigues (CEO), Ed Pershing (CEO), Heather Raines (CFO) and 2 others.
Affiliation history
-
Current
Company network
Leadership on record at Provectus Biopharmaceuticals, Inc.
- Dominic Rodrigues CEO
- Ed Pershing CEO
- Heather Raines CFO
- Eric Wachter CTO
- Webster Bailey Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Provectus Biopharmaceuticals, Inc. (PVCT) | CPA, Chief Executive Officer ^^ | $240,000 | $315,000 |
| 2024 | Provectus Biopharmaceuticals, Inc. (PVCT) | CPA, Chief Executive Officer | $170,000 | $2,147,650 |
| 2023 | Provectus Biopharmaceuticals, Inc. (PVCT) | CPA, Chief Executive Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.